Pharmacogenomics testing for clopidogrel responsiveness
10-1558
Phase 1 other completed
Quick answer
Pharmacogenomics testing for clopidogrel responsiveness for Stroke is a Phase 1 program (other) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BRIGHT MINDS BIOSCIENCES INC.
- Indication
- Stroke
- Phase
- Phase 1
- Modality
- other
- Status
- completed